AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 88 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 1.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $161,000 | -98.7% | 21,526 | -98.5% | 0.01% | -94.9% |
| Q1 2016 | $12,659,000 | -2.0% | 1,405,000 | +40.5% | 0.22% | +10.8% |
| Q4 2015 | $12,920,000 | +140.6% | 1,000,000 | +79.9% | 0.19% | +165.8% |
| Q3 2015 | $5,371,000 | +224.5% | 556,000 | +643.6% | 0.07% | +204.2% |
| Q3 2014 | $1,655,000 | -20.4% | 74,768 | 0.0% | 0.02% | -25.0% |
| Q2 2014 | $2,078,000 | – | 74,768 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 7,031,283 | $95,485,000 | 5.72% |
| GREAT POINT PARTNERS LLC | 3,510,073 | $47,667,000 | 3.81% |
| Logos Global Management LP | 1,200,000 | $16,296,000 | 3.26% |
| DAFNA Capital Management LLC | 762,666 | $10,357,000 | 2.99% |
| Baupost Group | 15,000,000 | $203,700,000 | 2.54% |
| Nantahala Capital Management | 6,101,111 | $82,853,000 | 2.50% |
| Abrams Capital Management | 5,656,462 | $76,815,000 | 2.48% |
| Novo Holdings A/S | 1,987,506 | $26,990,000 | 1.74% |
| Stanley-Laman Group, Ltd. | 316,933 | $4,304,000 | 1.04% |
| Integral Health Asset Management, LLC | 250,000 | $3,395,000 | 1.02% |